The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Joseph G. Jurcic

Department of Medicine

Leukemia Service

Memorial Sloan-Kettering Cancer Center

1275 York Avenue

USA

[email]@mskcc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, USA. 2000 - 2011
  • Department of Medicine, Memorial Sloan-Kettering Cancer Center and the Weill Medical College of Cornell University, New York, New York 10021, USA. 2000 - 2002
  • Leukemia, Hematology, and Developmental Chemotherapy Services, Department of Medicine, USA. 2001

References

  1. What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia? Jurcic, J.G. Curr. Hematol. Malig. Rep (2011) [Pubmed]
  2. Diagnosis and treatment of acute promyelocytic leukemia. Jurcic, J.G., Soignet, S.L., Maslak, A.P. Curr. Oncol. Rep (2007) [Pubmed]
  3. Immunotherapy for acute myeloid leukemia. Jurcic, J.G. Curr. Oncol. Rep (2005) [Pubmed]
  4. Monitoring PML-RARalpha in acute promyelocytic leukemia. Jurcic, J.G. Curr. Oncol. Rep (2003) [Pubmed]
  5. Targeted alpha particle immunotherapy for myeloid leukemia. Jurcic, J.G., Larson, S.M., Sgouros, G., McDevitt, M.R., Finn, R.D., Divgi, C.R., Ballangrud, A.M., Hamacher, K.A., Ma, D., Humm, J.L., Brechbiel, M.W., Molinet, R., Scheinberg, D.A. Blood (2002) [Pubmed]
  6. Antibody therapy for residual disease in acute myelogenous leukemia. Jurcic, J.G. Crit. Rev. Oncol. Hematol. (2001) [Pubmed]
  7. Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia. Jurcic, J.G., Nimer, S.D., Scheinberg, D.A., DeBlasio, T., Warrell, R.P., Miller, W.H. Blood (2001) [Pubmed]
  8. Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches. Jurcic, J.G., Cathcart, K., Pinilla-Ibarz, J., Scheinberg, D.A. Curr. Opin. Hematol. (2000) [Pubmed]
  9. Antibody therapy of acute myelogenous leukemia. Jurcic, J.G. Cancer Biother. Radiopharm. (2000) [Pubmed]
  10. Antibody immunotherapy for leukemia. Jurcic, J.G. Curr. Oncol. Rep (2000) [Pubmed]
 
WikiGenes - Universities